Medical, Scientific, and Regulatory Updates
MIKS curates reliable and high-quality information published in the field of regenerative medicine, ensuring you can effortlessly stay current.
Certain news pieces are exclusively available to members. If you wish for unrestricted access to all news articles, you can achieve that by becoming a member of our community. Join as a member today to enjoy complete access to all our content.
26 abril 2024
SCIENTIFIC HIGHLIGHTS
Use of injectable orthobiologics for the treatment of knee osteoarthritis. ESSKA ORBIT Consensus
The aim of this consensus, published by the European Society of Sports Traumatology, Knee Surgery and Arthroscopy (ESSKA), is to provide recommendations based on evidence and expert opinion to improve indications for decision-making and administration-related matters when using blood-derived orthobiologics (shown for simplicity as PRP—platelet-rich plasma—with PRP being the most common product) for the management of knee OA. The consensus group reached a high level of agreement on all the questions/statements despite the lack of clear evidence on some matters. According to the results from this consensus group, given the large body of existing literature and expert opinions, PRP was regarded as a valid treatment option for knee OA and as a possible first-line injectable treatment option for nonoperative management of knee OA, mainly for KL grades 1-3.
You can access the study HERE.
Image gallery